Khan Samina
- SEC CIK
- 0001903865
No open-market purchases or sales filed in the past year.
Current role at each company
- RETA Reata Pharmaceuticals IncSVP, Chief Medical Officeras of May 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Khan Samina as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 2-3 | 4 days | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −27.8K | $85.13 | −$2.37M | −38.7%44.1K after | 4 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −3.96K | $83.46 | −$330.6K | −9.0%40.1K after | |
| May 17, 2023 (view filing) | May 15-16 | 2 days | Khan SaminaSVP, Chief Medical Officer | SSaleClass A common stock | −640 | $83.15 | −$53.2K | −1.6%39.5K after | 2 lots |